Chapter 341
2024 -- S 2609 SUBSTITUTE A
Enacted 06/25/2024

A N   A C T
RELATING TO HEALTH AND SAFETY -- DENSE BREAST NOTIFICATION AND EDUCATION

Introduced By: Senators Valverde, Lawson, Sosnowski, Gallo, Lauria, Murray, DiMario, Ujifusa, Quezada, and Euer

Date Introduced: March 01, 2024

It is enacted by the General Assembly as follows:
     SECTION 1. Section 23-12.9-2 of the General Laws in Chapter 23-12.9 entitled "Dense
Breast Notification and Education" is hereby amended to read as follows:
     23-12.9-2. Public policy goals — Department of health.
     The department of health, through the Rhode Island Cancer Council, is authorized and
mandated to implement the following public health policy goals as they relate to dense breast
notification in Rhode Island. Commencing on October 1, 2014, all All healthcare facilities that
perform mammography examinations shall include in the summary of the mammography report to
be provided to a patient by mail, electronically, or otherwise, information that identifies the
patient’s individual Breast Tissue Classification based on the Breast Imaging Reporting and Data
System established by the American College of Radiology. If the The facility determines that a
patient has heterogeneously or extremely dense breasts, the summary of the mammography report
shall also include the following mandated FDA National Reporting Standard for breast density
patient notification language in the notice to the patient.:
     “Your mammogram indicates that you have dense breast tissue. Dense breast tissue is
relatively common and is found in about forty percent (40%) of women. The presence of dense
tissue can make it more difficult to detect cancers in the breast by mammography because it can
hide small abnormalities and may be associated with an increased risk. Hence, you may benefit
from supplementary screening tests, which may include a breast ultrasound screening, or a breast
MRI examination, or both, depending on your individual risk factors.
     We are providing this information to raise your awareness of this important factor and to
encourage you to discuss your dense breast tissue, as well as other breast cancer risk factors, with
your healthcare provider. Together, you can decide which screening options are right for you.
     A report of your results was sent to your physician. You should contact your physician if
you have any questions or concerns about this report.”
     SECTION 2. This act shall take effect upon passage.
========
LC005338/SUB A
========